Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00370617
What this trial is testing

Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance

Who this might be right for
Chronic Hepatitis CInsulin Resistance
University of Turin, Italy 200
Not applicableUnknownNCT00956982
What this trial is testing

PEG-IFN Plus Ribavirin Combination Therapy for Older Patients

Who this might be right for
Hepatitis C Virus
Kyushu University 1,251
Early research (Phase 1)Ended earlyNCT01554189
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 37
Not applicableWithdrawnNCT00547716
What this trial is testing

Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C
University of Missouri, Kansas City
Post-approval studies (Phase 4)Study completedNCT03144635
What this trial is testing

G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir

Who this might be right for
Hepatitis C ViralChronic Kidney Disease stage3
Kyushu University 80
Testing effectiveness (Phase 2)Study completedNCT01609933
What this trial is testing

Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study

Who this might be right for
Chronic Hepatitis C
AbbVie (prior sponsor, Abbott) 32
Testing effectiveness (Phase 2)Study completedNCT03501550
What this trial is testing

Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)

Who this might be right for
Chronic Hepatitis C
Cocrystal Pharma, Inc. 12
Large-scale testing (Phase 3)Study completedNCT03186313
What this trial is testing

Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C
Egyptian Liver Hospital 72
Not applicableUnknownNCT03488485
What this trial is testing

Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model

Who this might be right for
Chronic Hepatitis c
Post Graduate Institute of Medical Education and Research, Chandigarh 50,000
Early research (Phase 1)Study completedNCT03903081
What this trial is testing

The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects

Who this might be right for
Chronic Hepatitis C
Sunshine Lake Pharma Co., Ltd. 93
Post-approval studies (Phase 4)Study completedNCT00107653
What this trial is testing

Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 569
Large-scale testing (Phase 3)UnknownNCT01463592
What this trial is testing

To Study the Efficacy and Safety of Renessans in Chronic HCV Patients

Who this might be right for
Hepatitis C, Chronic
MTI Medical Private Limited, Pakistan 90
Post-approval studies (Phase 4)Study completedNCT00077636
What this trial is testing

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,469
Testing effectiveness (Phase 2)Study completedNCT01292161
What this trial is testing

Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Isfahan University of Medical Sciences 55
Not applicableUnknownNCT01360879
What this trial is testing

Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease

Who this might be right for
Chronic Hepatitis BChronic Hepatitis C
Kindai University 500
Not applicableStudy completedNCT00755742
What this trial is testing

Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C

Who this might be right for
ObesityInsulin ResistanceMetabolic Syndrome+1 more
University Health Network, Toronto 24
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Large-scale testing (Phase 3)Ended earlyNCT00678587
What this trial is testing

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Who this might be right for
Non-alcoholic SteatohepatitisChronic Liver DiseaseHCV+8 more
GlaxoSmithKline 292
Large-scale testing (Phase 3)Study completedNCT01448044
What this trial is testing

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 152
Testing effectiveness (Phase 2)Study completedNCT01051414
What this trial is testing

An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 43
Next Page